Health
New York: Pfizer Inc and BioNTech SE on Monday announced results from a Phase 2/3 trial showing a favorable safety profile and robust neutralizing antibody responses in children 5 to 11 years of age using a two-dose regimen of 10 µg administered 21 days apart, a smaller dose than the 30 µg dose used for people 12 and older. more
North Korea declines COVID-19 vaccine manufactured in China

UNICEF said on Thursday that North Korea has rejected around three million doses of a Chinese Covid-19 vaccine.

Vaccine inequity causes ‘dangerous divergence’ in COVID survival rates – UN agency heads

New York: The global rollout of COVID-19 vaccines is progressing at “two alarmingly different speeds”, UN agency leaders said in a statement on Friday, noting that less than t ...

Spanish doctors call for vaccinating pregnant women against COVID-19 after three deaths reported

Moscow/UNI/Sputnik: Spanish doctors called on regional authorities to accelerate the immunization of pregnant women following three reported cases of fatalities from COVID-19 in the categ ...

Thai authorities planning to mix Oxford's AstraZeneca with China's Sinovac vaccine amid rising COVID-19 cases

Bangkok: Thailand authorities have decided to mix Oxford's AstraZeneca with China's Sinovac vaccine to combat rising COVID-19 cases in the country.

One dose of Sputnik V reduces mortality rate in people aged over 60 by 70-80 pc, reveals study

Buenos Aires/Sputnik: Even one dose of the Sputnik V or AstraZeneca vaccines against the coronavirus reduces the mortality rate in people aged over 60 years by 70-80 percent, a study the ...

91 countries now offer COVID-19 vaccinations to refugees, says UNHCR

New York: UN refugee agency UNHCR, on Thursday welcomed the growing number of countries that have offered COVID-19 vaccines to refugees before urging others to do the same.

Bangladesh: Authorities clear homegrown Bangavax coronavirus vaccine for clinical trial with conditions

Dhaka: The Bangladesh Medical Research Council (BMRC) has decided to allow the Bangavax vaccine, a coronavirus vaccine produced by Bangladeshi company Globe Biotech, to be tested on human ...

COVID-19 cases drop for seventh week, but deaths fall less slowly: WHO

New York: The number of new COVID-19 cases reported to the UN health agency has declined for seven weeks in a row, in what the top official there called on Monday “the longest seque ...

Two doses of COVID-19 vaccines are highly effective against hospitalisation from Delta variant: PHE

London: New analysis by PHE shows for the first time that 2 doses of COVID-19 vaccines are highly effective against hospitalisation from the Delta (B.1.617.2) variant, Public Health Engla ...